Thus, HDAC3 inhibition caused replication stress in CTCL cells, and selective inhibition of HDAC3 through novel inhibitors may be useful in the treatment of CTCL. The gene discussed is HDAC3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.